Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
1120
-
Total 13F shares, excl. options
-
189M
-
Shares change
-
+15.8K
-
Total reported value, excl. options
-
$60B
-
Value change
-
+$9.89M
-
Put/Call ratio
-
1.3
-
Number of buys
-
477
-
Number of sells
-
-429
-
Price
-
$318.57
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q4 2017
1,230 filings reported holding BIIB - BIOGEN INC. - COM as of Q4 2017.
BIOGEN INC. - COM (BIIB) has 1,120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 189M shares
.
Largest 10 shareholders include BlackRock Inc. (16.8M shares), PRIMECAP MANAGEMENT CO/CA/ (15.1M shares), Vanguard Group Inc (14.9M shares), STATE STREET CORP (9.48M shares), Clearbridge Investments, LLC (9.14M shares), FMR LLC (9.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.53M shares), WELLINGTON MANAGEMENT GROUP LLP (5.11M shares), Invesco Ltd. (3.46M shares), and ALLIANCEBERNSTEIN L.P. (3.41M shares).
This table shows the top 1120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.